Based on these collective beneficial properties, the CCM-coated ELP-based nanomicelles exhibited remarkable therapeutic efficacy in the unilateral breast cancer mice model, demonstrating an 87.7 % tumor weight inhibition accompanied by characteristic DNA fragmentation and significantly reduced proliferation markers (Ki-67) in residual tumors after 14-day treatment. Here, MKI67 is linked to neoplasm.